FUNCTIONAL GASTROINTESTINAL DISORDERS: SELECT FROM THE POINT PROKINETIC COMORBIDITY, CLINICAL EFFICACY AND DRUG SAFETY

FUNCTIONAL GASTROINTESTINAL DISORDERS: SELECT FROM THE POINT PROKINETIC COMORBIDITY, CLINICAL EFFICACY AND DRUG SAFETY

Functional gastrointestinal disorders are currently being considered as the most common pathology of the gastrointestinal tract. Symptoms that may be related to the gastroduodenal region, represent one of the major subgroups among functional gastrointestinal disorders, in which the functional dyspep...

Full description

Bibliographic Details
Main Author:	D. I. Trukhan
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2017-12-01
Series:	Медицинский совет
Subjects:	functional gastrointestinal disorders functional dyspepsia gastroesophageal reflux disease prokinetics itopride hydrochloride itopra ®
Online Access:	https://www.med-sovet.pro/jour/article/view/1801

Similar Items

Current status and prospects of using the prokinetic acotiamide in gastroenterology: A review
by: Igor V. Maev, et al.
Published: (2023-10-01)

Therapeutic role of prokinetic drugs in the treatment of gastroesophageal reflux disease
by: I. V. Mayev, et al.
Published: (2014-12-01)

Gastritis and dyspepsia: 2 names of one problem? Relations between predominant symptom and syndromal characteristics of upper GI disorders: results of a survey of physicians
by: N. V. Bakulina, et al.
Published: (2021-10-01)

A Prokinetic Agent with a Dual Effect – Itopride – In the Treatment of Dysmotility
by: Petr Dite, et al.
Published: (2014-12-01)

Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis
by: Qingqing Qi, et al.
Published: (2023-10-01)

Place and choice of prokinetic in treatment of gastroesophageal reflux disease
by: V. I. Kasyanenko
Published: (2013-12-01)

The Role of Motility Impairment in the Pathogenesis of Functional Disorders of the Gastrointestinal Tract and Modern Possibilities for Their Treatment (Resolution of an Expert Council and Literature Review)
by: I. V. Maev, et al.
Published: (2020-01-01)

Efficacy of Itopride in Treatment of Gastroparesis Considering the State of Carbohydrate Metabolism in Patients with Type 2 Diabetes Mellitus
by: Kostitska I.
Published: (2015-12-01)

Rikkunshito as a Therapeautic Agent for Functional Dyspepsia and its Prokinetic and Non-Prokinetic Effects
by: Kazumi Inokuchi, et al.
Published: (2021-06-01)

Efficacy and safety of pantoprazole and itopride in patients with overlap of gastroesophageal reflux disease and dyspepsia: A prospective, open‐label, single‐arm pilot study
by: Sundeep Lakhtakia, et al.
Published: (2024-02-01)

Modern Possibilities of Using Acotiamide in the Treatment of Functional Dyspepsia
by: A. A. Sheptulin, et al.
Published: (2024-03-01)

The efficacy and safety of itopride as an add-on therapy to a proton pump inhibitor in the treatment of gastroesophageal reflux disease
by: Dorota Wasko-Czopnik, et al.
Published: (2023-12-01)

Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract
by: Kazunari eTominaga, et al.
Published: (2015-01-01)

Interaction of glimepiride with prokinetic drugs on some of gastrointestinal functions in STZ-induced diabetic mice
by: Mohamed A. Fouad, et al.
Published: (2013-06-01)

Characterization of esophageal motor activity, gastroesophageal reflux, and evaluation of prokinetic effectiveness in mechanically ventilated critically ill patients: a high-resolution impedance manometry study
by: Karel Balihar, et al.
Published: (2021-02-01)

Use of itopride in the symptoms of functional dyspepsia in Russia: Results of a Phase IV prospective open-label multicenter clinical trial
by: V I Kas'ianenko, et al.
Published: (2014-08-01)

Itopride increases the effectiveness of the management of opioid-induced constipation in palliative care patients: an observational non-interventional study
by: Tomasz Dzierżanowski, et al.
Published: (2019-07-01)

Overlap of Gastroesophageal Reflux Disease and Functional Dyspepsia and Yield of Esophagogastroduodenoscopy in Patients Clinically Fulfilling the Rome IV Criteria for Functional Dyspepsia
by: Duc Trong Quach, et al.
Published: (2022-06-01)

Prevalence and risk factors of upper gastrointestinal symptoms in community pharmacies in Spain: a cross-sectional study
by: María Puig-Moltó, et al.
Published: (2023-06-01)

GASTROESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH FUNCTIONAL DYSPEPSIA AND CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME: CLINICAL FEATURES AND EFFICACY OF LACTULOSE AND ITOPRIDE HYDROCHLORIDE
by: O. V. Krapivnaya, et al.
Published: (2016-02-01)

Gastric motility disorders in adolescents with gastroesophageal reflux disease and functional dyspepsia
by: V.L. Kashina-Yarmak, et al.
Published: (2019-04-01)

Functional Dyspepsia and Chronic Gastritis: Similarities and Differences
by: S.M. Tkach
Published: (2014-09-01)

Rational treatment of patients with functional dyspepsia
by: Alexander S. Kazakov, et al.
Published: (2021-08-01)

Helicobacter pylori and Other Gastrointestinal Diseases
by: Jong Kyu Park
Published: (2020-03-01)

Differentiated approach to the choice of PPI in a patient with GERD in the practice of an outpatient (with a clinical case)
by: I. G. Pakhomova, et al.
Published: (2020-10-01)

Differentiation therapy for non-acidic gastroesophageal reflux disease
by: N B Lishchuk, et al.
Published: (2017-04-01)

The Laxative and Prokinetic Effects of Rosa damascena Mill in Rats
by: Reza Arezoomandan, et al.
Published: (2011-01-01)

Efficacy and Safety of Domperidone in Combination with Proton Pump Inhibitors in Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
by: Nur Fathurah Zamani, et al.
Published: (2022-09-01)

Functional dyspepsia and its treatment methods
by: S. A. Baranov, et al.
Published: (2020-02-01)

Efficacy and safety of itopride SR for upper gastrointestinal symptoms in patients with diabetic gastroparesis: real-world evidence from Pakistan
by: Adil Ramzan, et al.
Published: (2023-12-01)

Gastroesophageal reflux disease: new approaches to optimizing pharmacotherapy
by: D. N. Andreev, et al.
Published: (2021-05-01)

COMPARISON OF PROKINETIC ACTIVITY OF RANITIDINE AND NEOSTIGMINE ALONE AND IN COMBINATION- AN IN VITRO STUDY
by: Aroosa Ishtiaq Butt, et al.
Published: (2021-01-01)

Clinical manifestations of precancerous lesions of the stomach: characteristics and warnings
by: I.V. Kushnirenko, et al.
Published: (2020-02-01)

Gastroesophageal reflux disease and functional dyspepsia: What is the real burden on health-related quality of life?
by: Babič Tamara, et al.
Published: (2018-01-01)

A case of superior mesenteric artery syndrome characterized by deep forward bending posture in a cross‐legged position on the floor
by: Hiroki Isono, et al.
Published: (2023-04-01)

Dyspepsia: literature review and evidence for management in primary care
by: M. Torlutter, et al.
Published: (2018-07-01)

Gastrointestinal symptoms in adult population of Novosibirsk city: prevalence and risk factors
by: Oleg Veniaminovich Peshetnikov, et al.
Published: (2009-02-01)

Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study
by: Dorte Ejg Jarbøl, et al.
Published: (2017-05-01)

Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problem
by: M. A. Osadchuk, et al.
Published: (2020-02-01)

Comparison of the effects of individual symptoms of gastroesophageal reflux disease co‐existing functional dyspepsia on patients' daily lives: A prospective, observational study
by: Tatsuya Nakada, et al.
Published: (2022-12-01)